Matches 1 - 50 out of 61 1 2 >


Match Document Document Title
US20150297763 DEVICES AND METHODS FOR THERAPEUTIC HEAT TREATMENT  
A microparticle includes a plurality of magnetic nanoparticles having a Curie temperature between 40° and 100° C. The microparticle further includes a biocompatible polymer and/or biocompatible...
US20150104386 ISOTOPE PREPARATION METHOD  
The present invention provides a method for the generation of 223Ra of pharmaceutically tolerable purity comprising i) preparing a generator mixture comprising 227Ac, 227Th and 223Ra; ii) loading...
US20160367709 DEVICES AND METHODS FOR THE TREATMENT OF CANCER  
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a...
US20140193335 DEVICES AND METHODS FOR THE TREATMENT OF CANCER  
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a...
US20120082616 Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers  
The present invention provides targeted delivery compositions and their methods of use in treating and diagnosing a disease state in a subject.
US20160038413 Antimicrobial Amorphous Compositions  
The present invention comprises compositions and methods for providing antimicrobial compositions. The antimicrobial compositions comprise gel delivery vehicles comprising stabilized silver,...
US20100015048 Internalizing Anti-CD74 Antibodies and Methods of Use  
The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major...
US20100076489 WOUND CLOSURE MATERIAL  
Articles are provided having no orientation or a multi-directional orientation. Such articles may be in the form of films, ribbons, sheets, and/or tapes and may be utilized as buttresses with a...
US20150359808 COMPOSITIONS AND METHODS FOR REDUCING HEPATOTOXICITY ASSOCIATED WITH DRUG ADMINISTRATION  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
US20120134921 SOLID COMPOSITIONS COMPRISING 5-AMINOLEVULINIC ACID  
This invention relates to solid compositions and solid pharmaceutical products for use in methods of photodynamic diagnosis of cancer, pre-cancerous and non-cancerous conditions in the lower part...
US20090297441 Imaging Agents  
The use of silicon as an imaging agent is described.
US20070248540 Biochemical methods for measuring metabolic fitness of tissues or whole organisms  
The present invention relates to biochemical methods for assessing metabolic fitness and/or aerobic demands of a living system. Specifically, the rate of synthesis and turnover of the molecular...
US20160122406 ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE  
This invention relates to analogs of pituitary adenylate cyclase-activating polypeptide (PACAP), which are agonists for the PACAP/vasoactive intestinal peptide (VIP) receptors: PAC1, VPAC1 and...
US20120282179 Methods of Using C-Met Modulators  
Methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments are described, wherein R1...
US20080213172 RADIOIMAGING MOIETIES COUPLED TO PEPTIDEASE-BINDING MOIETIES FOR IMAGING TISSUES AND ORGANS THAT EXPRESS PEPTIDASES  
Conjugates, methods and kits are described for imaging tissues and organs that express one or more peptidases. In a preferred embodiment of the invention, a series of di-(2-pyridylmethyl)amine (D)...
US20110150762 BONE CEMENT CONTAINING BONE MARROW  
A bone cement configured to be introduced to a target bone location and allowed to cure includes at least a monomer, and an amount of bone marrow. The resulting cured bone cement includes at least...
US20090202434 Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix  
The present invention refers to a pharmaceutical composition for treating skin lesion, comprising a cerium salt on a collagen matrix and a dermatologically acceptable carrier. The present...
US20080206134 Radio-opaque hemostatic agents and devices and methods for the delivery thereof  
A radiographic composition for promoting the formation of clots in blood includes a zeolite and iodine. A device for promoting the clotting of blood at an internal wound site includes a catheter;...
US20100143247 DIAGNOSIS OF PROSTATE CANCER  
The present invention provides a method for determining the presence of prostate cancer in a subject which method comprises determining the level of expression of one or more markers in a blood...
US20130224112 COMPOSITIONS AND METHODS FOR SURFACE ABRASION WITH FROZEN PARTICLES  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
US20140079630 CARBON NANOTUBES FOR IMAGING AND DRUG DELIVERY  
The invention provides compositions and methods for visualizing particular tissues and delivering one or more therapeutics to that tissue using single-walled carbon nanotubes (SWNTs), which are...
US20160298199 NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER  
The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used...
US20090155167 AUTOMATED METHOD  
The present invention provides an automated method for the preparation of 99mTc radiopharmaceutical compositions, together with disposable cassettes for use in the method. The use of an automated...
US20140308342 REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT  
The present invention relates to chimeric (preferably, bifunctional) compounds, compositions comprising those compounds and methods of treating cancer in a patient or subject, especially including...
US20130343988 Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer  
The invention is directed to Compounds of Formula (I). The invention provides compounds that inhibit, regulate, and/or modulate P13K that are useful in the treatment of hyperproliferative...
US20100111857 Compositions and methods for surface abrasion with frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
US20140093451 Coupled identification and treatment of cancer  
Provided are methods to treat cancer, in which (1) a patient is first identified as having a cancer that is likely to be susceptible to gallium therapy, by the use of a gallium scan or other...
US20110064655 BIOMARKERS FOR DEPRESSION  
Differential expression of nucleic acids in the brains of subjects suffering from late-onset depression has been demonstrated. The invention provides methods useful in the determination of...
US20110318265 Coupled identification and treatment of cancer  
Provided are methods to treat cancer in which a patient is identified as having gallium-avid cancer by use of a gallium scan or other means, and is then treated with a pharmaceutically acceptable...
US20160166637 METHODS OF TREATING A CANCER THROUGH TARGETED DISRUPTION OF ALPHA CONNEXIN 43-ZONULA OCCLUDENS-1 (ZO-1) INTERACTION  
The present disclosure describes methods of treating a cancer based on the targeted disruption of alpha connexin 43-zonula occludens-1 (ZO-1) interaction. The methods may include administering to...
US20100196268 Compositions and methods for treatment of tumors by direct administration of a radioisotope  
This invention provides a safer and more effective treatment for non-intracavitary undesirable tissue masses, especially bone cancer and soft tissue tumors. The method involves the direct...
US20110301401 COMPOSITIONS AND METHODS FOR THERMORADIOTHERAPY  
The present invention relates to compositions and methods for increasing tissue-radiosensitivity through induction of local hyperthermia. In particular, the present invention provides...
US20090246126 Thulium-based capsule and devices for use in high dose rate brachytherapy  
A capsule for high dose rate brachytherapy, wherein the capsule comprises within its interior space thulium-170, and further comprises at least one layer of a radiation emission modifying metal...
US20090117039 CHARGED BIODEGRADABLE POLYMERS FOR MEDICAL APPLICATIONS  
In accordance with one aspect of the invention, implantable medical devices are provided which include polymeric compositions that comprise at least one type of biodegradable ionic polymer. The at...
US20080193376 Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation  
The present invention relates to methods for the detection and therapy of active atheromatous plaques, and in particular vulnerable plaques, whereby immune modulators are used to increase the...
US20090285750 AGENT, COMPOSITION AND METHOD  
The present application relates to agents, compositions and methods for use in medicine. In particular, the application relates to an agent comprising a binding moiety capable of selectively...
US20120027675 TARGETING PULMONARY EPITHELIUM USING ADRP  
This invention provides novel compositions and methods for the specific and/or preferential delivery of an effector (e.g. a drug or label) to an epithelial cell (e.g. a pulmonary epithelium). The...
US20160296644 ANTICANCER DRUG, COMPRISING A COPPER RADIOISOTOPE  
The object of the present invention is a drug for the therapeutic treatment of tumours, also usable as diagnostic agent and therapeutic agent for the Alzheimer's disease. Such drug comprises a...
US20090191122 METHOD FOR PURIFICATION OF 225AC FROM IRRADIATED 226RA-TARGETS  
The present invention describes a method for purification of 225Ac from irradiated 226Ra-targets provided on a support, comprising a leaching treatment of the 226Ra-targets for leaching...
US20120095324 METHOD FOR A NUCLEAR MEDICINE EXAMINATION  
A method for a nuclear medicine examination of a patient is disclosed. In at least one embodiment of the method, a magnetic resonance recording of an examination region of the patient is created...
US20130004418 INFILTRATION SOLUTION FOR TREATING AN ENAMEL LESION  
The invention relates to an infiltration solution of a radiopaque metal compound for treating an enamel lesion, to a kit for dental application, and to the use thereof for preventing and/or...
US20120251442 Methods for Treatment of Tumors by Direct Administration of a Radioisotope  
This invention provides a safer and more effective treatment for non-intracavitary undesirable tissue masses, especially bone cancer and soft tissue tumors. The method involves the direct...
US20080138277 Delivery systems and methods for diagnosing and treating cardiovascular diseases  
The invention relates to the treatment and prevention of atherosclerosis and cardiovascular diseases associated with atherosclerosis. The invention further relates to methods of diagnosing...
US20120052008 NANOSTRUCTURES COMPRISING RADIOISOTOPES AND/OR METALS  
Nanostructures comprising radioisotopes and/or metals are provided. More particularly, in some embodiments, nanostructures comprising radioisotopes and/or metals, methods of their synthesis, and...
US20100331676 GAMMA PROBE DETECTION OF AMYLOID PLAQUE USING RADIOLABELED A-BETA BINDING COMPOUNDS  
The present invention relates to a method of detecting β-amyloid peptide aggregates in the brain of an individual and kits thereto. The method includes administering to an individual an effective...
US20100135903 USE OF A DNA DAMAGING AGENT AND A LIGAND FOR THE TREATMENT OF CANCER  
The present invention relates generally to a method of treating a neoplastic condition and to agents useful for same. More particularly, the present invention is directed to a method of...
US20130230458 Cell Permeable Inhibitors of Anaphase Promoting Complex  
The invention provides compositions and methods for treating cell cycle disorders. Compositions of the invention include proTAME, a prodrug analog of TAME, and, optionally, one or more therapeutic...
US20100284912 HOMOGENIZATION OF A RADIOPHARMACEUTICAL USING SONIFICATION AND/OR ROTOR-STATOR TECHNOLOGY TO PRODUCE A HOMOGENOUS SUSPENSION, EMULSION, MIXTURE OR SOLID SUSPENSION OF IMMISCIBLE INGREDIENTS  
A homogenous dispersion of aqueous droplets of a radiopharmaceutical or radiodiagnostic agent within a non-aqueous medium and method of making the same is provided. The homogenous dispersion is...
US20140341803 STABLE NANOEMULSIONS USEFUL IN THE TREATMENT OF CANCER  
Described herein are methods for treating a tumor or cancer in a subject. The methods involve administering to the subject a nanoemulsion comprising (1) at least one perfluoro crown ether and (2)...
US20100150830 METHOD OF TREATING CANCER  
A method and composition for administering a therapeutic agent to a lesion comprising a contrast/carrier agent and ethanol.

Matches 1 - 50 out of 61 1 2 >